Literature DB >> 11304760

Effect of MPTP-induced denervation on basal ganglia GABA(B) receptors: correlation with dopamine concentrations and dopamine transporter.

F Calon1, N Lavertu, A M Lemieux, M Morissette, M Goulet, R Grondin, P J Blanchet, P J Bédard, T Di Paolo.   

Abstract

We investigated the effect of MPTP-induced lesion of the substantia nigra pars compacta (SNpc) dopaminergic neurons on GABA(B) receptors in the basal ganglia of mice and monkeys using receptor autoradiography and in situ hybridization. The extent of the lesion was measured with striatal catecholamine content, striatal binding of (125)I-RTI-121 to dopamine transporter (DAT), and DAT expression in the SNpc. GABA(B) receptors in mice brain were evaluated using (3)H-CGP54626 and its expression was measured with oligonucleotides probes targeting the mRNAs of GABA(B(1a+b)), GABA(B(1a)), GABA(B(1b)), GABA(B(2)) subunits. In monkeys, (125)I-CGP64213 and selective probes for GABA(B(1a+b)) and GABA(B(2)) mRNAs were used. In mice, dopamine content, (125)I-RTI-121 binding, and DAT expression were reduced by 44%, 40%, and 39% after a dose of 40 mg/kg of MPTP and 74%, 70%, and 34% after 120 mg/kg of MPTP, respectively. In monkeys, dopamine content and DAT expression were decreased by more than 90% and 80%, respectively. In the striatum and the subthalamic nucleus, GABA(B) receptors were unchanged following MPTP in both species. In the SNpc of mice, MPTP (120 mg/kg) induced a significant decrease of (3)H-CGP54626 binding (-10%) and of the expression of GABA(B(1a+b)) mRNA (-13%). The decrease of the expression of GABA(B(1a+b)) mRNA was correlated with dopamine content, (125)I-RTI-121 binding and DAT expression. In MPTP-treated monkeys, (125)I-CGP64213 binding (-40%), GABA(B(1a+b)) mRNA (-69%) and GABA(B(2)) mRNA (-66%) were also significantly decreased in the SNpc. Our results suggest that MPTP-induced denervation is associated with a decrease of GABA(B) receptors restricted to the SNpc. These observations may be relevant to the pathophysiology of motor disorders involving dysfunction of the basal ganglia such as Parkinson disease. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11304760     DOI: 10.1002/syn.1045

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  8 in total

1.  Decreased GABA(B) receptors in the cingulate cortex and fusiform gyrus in autism.

Authors:  Adrian L Oblak; Terrell T Gibbs; Gene J Blatt
Journal:  J Neurochem       Date:  2010-06-12       Impact factor: 5.372

2.  Interleukin-22 protects rat PC12 pheochromocytoma cells from serum deprivation-induced cell death.

Authors:  Yongchun Liu; Wenyan Pan; Shengmei Yang; Xiaoying Wu; Jianfu Wu; Jun Ma; Zengqiang Yuan; Songshu Meng
Journal:  Mol Cell Biochem       Date:  2012-09-16       Impact factor: 3.396

3.  Protective effects of resveratrol and quercetin against MPP+ -induced oxidative stress act by modulating markers of apoptotic death in dopaminergic neurons.

Authors:  Julie Bournival; Patrik Quessy; Maria-Grazia Martinoli
Journal:  Cell Mol Neurobiol       Date:  2009-12       Impact factor: 5.046

Review 4.  Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease.

Authors:  Susan Duty; Peter Jenner
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

5.  24-Epibrassinolide, a Phytosterol from the Brassinosteroid Family, Protects Dopaminergic Cells against MPP-Induced Oxidative Stress and Apoptosis.

Authors:  Julie Carange; Fanny Longpré; Benoit Daoust; Maria-Grazia Martinoli
Journal:  J Toxicol       Date:  2011-06-03

6.  The role of the MYD88-dependent pathway in MPTP-induced brain dopaminergic degeneration.

Authors:  Janelle Drouin-Ouellet; Claire Gibrat; Mélanie Bousquet; Frédéric Calon; Jasna Kriz; Francesca Cicchetti
Journal:  J Neuroinflammation       Date:  2011-10-11       Impact factor: 8.322

7.  GABAB Receptors in Neurodegeneration.

Authors:  Alessandra P Princivalle
Journal:  Curr Top Behav Neurosci       Date:  2022

8.  Impact of intravenous immunoglobulin on the dopaminergic system and immune response in the acute MPTP mouse model of Parkinson's disease.

Authors:  Isabelle St-Amour; Mélanie Bousquet; Isabelle Paré; Janelle Drouin-Ouellet; Francesca Cicchetti; Renée Bazin; Frédéric Calon
Journal:  J Neuroinflammation       Date:  2012-10-09       Impact factor: 8.322

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.